Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 08:07 ET | Source: Scienture Holdings, Inc.

SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update

Reports Significant Revenue Growth and Gross Margin Expansion in 2025 COMMACK, NY, March 30, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for...
March 13, 2026 13:15 ET | Source: Cohen Milstein Sellers & Toll PLLC

Eve-of-Trial $65M Settlement Preliminarily Approved in Novel Antitrust Class Action Against J&J Subsidiary Actelion Pharmaceuticals

Plaintiffs alleged the anticompetitive scheme forced Tracleer purchasers to pay higher prices and delayed market entry of less-costly generic versions.
March 11, 2026 08:00 ET | Source: George Medicines

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea GMRx2 is an innovative single pill combination of three medicines designed to deliver...
February 25, 2026 07:00 ET | Source: George Medicines

George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia

GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination therapy early in the treatment pathway, supported by an...
February 17, 2026 07:00 ET | Source: Essential Pharma

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertensionAcquisition reinforces Essential Pharma’s mission to serve the needs of rare disease...
January 28, 2026 04:58 ET | Source: Research and Markets

Global Supraventricular Tachycardia Market to Hit $1 Billion by 2030, Driven by Innovations in Electrophysiology

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Supraventricular Tachycardia - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for...
December 03, 2025 09:00 ET | Source: Rimidi

Brevard Health Alliance Improves Hypertension Control with RPM Program Utilizing Rimidi's Platform and Connected Devices

Atlanta, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Rimidi, a market-leading digital health company that supports healthcare providers with EHR-integrated software, services, and connected devices, recently...
December 02, 2025 04:00 ET | Source: AKAMPION

tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH

6-month GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated by Stanford University in mid-2026 Kiel, GERMANY,...
November 06, 2025 10:23 ET | Source: Research and Markets

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Chronic Heart Failure Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering....
November 04, 2025 11:22 ET | Source: Research and Markets

AI-Powered Acute Stroke Triage Research Report 2025: Market to Reach $3.83 Billion by 2029 at a CAGR of 22.2%, Amid Push for Faster, Smarter Emergency Care - Global Long-term Forecast to 2034

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The artificial...